116903,1,Admission,O
116903,1,Date,O
116903,1,:,O
116903,1,[,O
116903,1,**2138-3-20**,O
116903,1,],O
116903,1,Discharge,O
116903,1,Date,O
116903,1,:,O
116903,1,[,O
116903,1,**2138-4-7**,O
116903,1,],O
116903,1,Date,O
116903,1,of,O
116903,1,Birth,O
116903,1,:,O
116903,1,[,O
116903,1,**2091-2-17**,O
116903,1,],O
116903,1,Sex,O
116903,1,:,O
116903,1,M,O
116903,1,Service,O
116903,1,:,O
116903,1,Medicine,O
116903,1,HISTORY,O
116903,1,OF,O
116903,1,PRESENT,O
116903,1,ILLNESS,O
116903,1,:,O
116903,1,The,O
116903,1,patient,O
116903,1,is,O
116903,1,a,O
116903,1,47-year-old,O
116903,1,gentleman,O
116903,1,with,O
116903,1,hepatitis,O
116903,1,C,O
116903,1,cirrhosis,O
116903,1,who,O
116903,1,is,O
116903,1,high,O
116903,1,up,O
116903,1,on,O
116903,1,the,O
116903,1,transplant,O
116903,1,list,O
116903,1,",",O
116903,1,who,O
116903,1,for,O
116903,1,the,O
116903,1,last,O
116903,1,five,O
116903,1,days,O
116903,1,prior,O
116903,1,to,O
116903,1,admission,O
116903,1,had,O
116903,1,been,O
116903,1,having,O
116903,1,decreased,O
116903,1,appetite,O
116903,1,",",O
116903,1,fatigue,O
116903,1,",",O
116903,1,nausea,O
116903,1,",",O
116903,1,and,O
116903,1,occasional,O
116903,1,vomiting,O
116903,1,.,O
116903,1,The,O
116903,1,patient,O
116903,1,'s,O
116903,1,diuretics,B-Drug
116903,1,were,O
116903,1,recently,O
116903,1,increased,O
116903,1,prior,O
116903,1,to,O
116903,1,admission,O
116903,1,to,O
116903,1,Lasix,B-Drug
116903,1,40,O
116903,1,and,O
116903,1,Aldactone,B-Drug
116903,1,100,O
116903,1,",",O
116903,1,but,O
116903,1,they,O
116903,1,were,O
116903,1,decreased,O
116903,1,to,O
116903,1,Lasix,B-Drug
116903,1,20,O
116903,1,and,O
116903,1,Aldactone,B-Drug
116903,1,50,O
116903,1,for,O
116903,1,elevated,B-ADE
116903,1,creatinines,I-ADE
116903,1,.,O
116903,1,The,O
116903,1,patient,O
116903,1,was,O
116903,1,found,O
116903,1,to,O
116903,1,have,O
116903,1,acute,O
116903,1,renal,O
116903,1,insufficiency,O
116903,1,by,O
116903,1,laboratories,O
116903,1,in,O
116903,1,clinic,O
116903,1,and,O
116903,1,was,O
116903,1,asked,O
116903,1,to,O
116903,1,come,O
116903,1,to,O
116903,1,the,O
116903,1,Emergency,O
116903,1,Department,O
116903,1,for,O
116903,1,further,O
116903,1,evaluation,O
116903,1,.,O
116903,1,In,O
116903,1,the,O
116903,1,Emergency,O
116903,1,Department,O
116903,1,",",O
116903,1,laboratories,O
116903,1,revealed,O
116903,1,a,O
116903,1,potassium,O
116903,1,of,O
116903,1,6.7,O
116903,1,and,O
116903,1,a,O
116903,1,creatinine,O
116903,1,of,O
116903,1,4.3,O
116903,1,.,O
116903,1,PAST,O
116903,1,MEDICAL,O
116903,1,HISTORY,O
116903,1,:,O
116903,1,(,O
116903,1,Significant,O
116903,1,for,O
116903,1,),O
116903,1,1,O
116903,1,.,O
116903,1,Hepatitis,O
116903,1,C,O
116903,1,cirrhosis,O
116903,1,;,O
116903,1,requiring,O
116903,1,liver,O
116903,1,transplantation,O
116903,1,",",O
116903,1,the,O
116903,1,patient,O
116903,1,is,O
116903,1,currently,O
116903,1,on,O
116903,1,liver,O
116903,1,transplant,O
116903,1,list,O
116903,1,.,O
116903,1,2,O
116903,1,.,O
116903,1,Hypertension,O
116903,1,.,O
116903,1,3,O
116903,1,.,O
116903,1,History,O
116903,1,of,O
116903,1,nephrolithiasis,O
116903,1,.,O
116903,1,MEDICATIONS,O
116903,1,ON,O
116903,1,ADMISSION,O
116903,1,:,O
116903,1,1,O
116903,1,.,O
116903,1,Aldactone,B-Drug
116903,1,50,O
116903,1,mg.,O
116903,1,2,O
116903,1,.,O
116903,1,Lasix,B-Drug
116903,1,20,O
116903,1,mg.,O
116903,1,3,O
116903,1,.,O
116903,1,Flagyl,B-Drug
116903,1,250,O
116903,1,mg,O
116903,1,three,O
116903,1,times,O
116903,1,per,O
116903,1,day,O
116903,1,.,O
116903,1,4,O
116903,1,.,O
116903,1,Quinine,B-Drug
116903,1,325,O
116903,1,mg,O
116903,1,once,O
116903,1,per,O
116903,1,day,O
116903,1,.,O
116903,1,5,O
116903,1,.,O
116903,1,Protonix,B-Drug
116903,1,40,O
116903,1,mg,O
116903,1,once,O
116903,1,per,O
116903,1,day,O
116903,1,.,O
116903,1,6,O
116903,1,.,O
116903,1,Magnesium,B-Drug
116903,1,oxide,I-Drug
116903,1,800,O
116903,1,mg,O
116903,1,twice,O
116903,1,per,O
116903,1,day,O
116903,1,.,O
116903,1,7,O
116903,1,.,O
116903,1,Oxycodone,B-Drug
116903,1,2,O
116903,1,mg,O
116903,1,to,O
116903,1,4,O
116903,1,mg,O
116903,1,as,O
116903,1,needed,O
116903,1,.,O
116903,1,ALLERGIES,O
116903,1,:,O
116903,1,The,O
116903,1,patient,O
116903,1,has,O
116903,1,allergies,B-ADE
116903,1,to,O
116903,1,CODEINE,B-Drug
116903,1,(,O
116903,1,which,O
116903,1,causes,O
116903,1,gastrointestinal,B-ADE
116903,1,upset,I-ADE
116903,1,),O
116903,1,.,O
116903,1,SOCIAL,O
116903,1,HISTORY,O
116903,1,:,O
116903,1,He,O
116903,1,lives,O
116903,1,at,O
116903,1,home,O
116903,1,with,O
116903,1,his,O
116903,1,wife,O
116903,1,.,O
116903,1,[,O
116903,1,**Name,O
116903,1,(,O
116903,1,NI,O
116903,1,),O
116903,1,**,O
116903,1,],O
116903,1,is,O
116903,1,a,O
116903,1,past,O
116903,1,alcohol,O
116903,1,abuser,O
116903,1,who,O
116903,1,now,O
116903,1,works,O
116903,1,as,O
116903,1,a,O
116903,1,substance,O
116903,1,abuse,O
116903,1,counselor,O
116903,1,.,O
116903,1,FAMILY,O
116903,1,HISTORY,O
116903,1,:,O
116903,1,Significant,O
116903,1,for,O
116903,1,father,O
116903,1,who,O
116903,2,died,O
116903,2,of,O
116903,2,a,O
116903,2,myocardial,O
116903,2,infarction,O
116903,2,at,O
116903,2,the,O
116903,2,age,O
116903,2,of,O
116903,2,38,O
116903,2,.,O
116903,2,PHYSICAL,O
116903,2,EXAMINATION,O
116903,2,ON,O
116903,2,PRESENTATION,O
116903,2,:,O
116903,2,On,O
116903,2,admission,O
116903,2,",",O
116903,2,the,O
116903,2,patient,O
116903,2,was,O
116903,2,afebrile,O
116903,2,.,O
116903,2,He,O
116903,2,had,O
116903,2,a,O
116903,2,blood,O
116903,2,pressure,O
116903,2,of,O
116903,2,130/58,O
116903,2,",",O
116903,2,a,O
116903,2,pulse,O
116903,2,of,O
116903,2,70,O
116903,2,",",O
116903,2,a,O
116903,2,respiratory,O
116903,2,rate,O
116903,2,of,O
116903,2,20,O
116903,2,",",O
116903,2,and,O
116903,2,was,O
116903,2,saturating,O
116903,2,97,O
116903,2,%,O
116903,2,on,O
116903,2,room,O
116903,2,air,O
116903,2,.,O
116903,2,He,O
116903,2,was,O
116903,2,in,O
116903,2,no,O
116903,2,apparent,O
116903,2,distress,O
116903,2,.,O
116903,2,He,O
116903,2,was,O
116903,2,anicteric,O
116903,2,.,O
116903,2,His,O
116903,2,pupils,O
116903,2,were,O
116903,2,reactive,O
116903,2,.,O
116903,2,His,O
116903,2,extraocular,O
116903,2,movements,O
116903,2,were,O
116903,2,intact,O
116903,2,.,O
116903,2,The,O
116903,2,lungs,O
116903,2,were,O
116903,2,clear,O
116903,2,bilaterally,O
116903,2,.,O
116903,2,His,O
116903,2,cardiac,O
116903,2,examination,O
116903,2,showed,O
116903,2,normal,O
116903,2,first,O
116903,2,heart,O
116903,2,sounds,O
116903,2,and,O
116903,2,second,O
116903,2,heart,O
116903,2,sounds,O
116903,2,with,O
116903,2,a,O
116903,2,2/6,O
116903,2,systolic,O
116903,2,murmur,O
116903,2,at,O
116903,2,the,O
116903,2,right,O
116903,2,upper,O
116903,2,sternal,O
116903,2,border,O
116903,2,.,O
116903,2,His,O
116903,2,abdomen,O
116903,2,was,O
116903,2,soft,O
116903,2,",",O
116903,2,mildly,O
116903,2,distended,O
116903,2,",",O
116903,2,and,O
116903,2,nontender,O
116903,2,.,O
116903,2,He,O
116903,2,had,O
116903,2,no,O
116903,2,peripheral,O
116903,2,edema,O
116903,2,.,O
116903,2,PERTINENT,O
116903,2,LABORATORY,O
116903,2,VALUES,O
116903,2,ON,O
116903,2,PRESENTATION,O
116903,2,:,O
116903,2,He,O
116903,2,had,O
116903,2,a,O
116903,2,white,O
116903,2,blood,O
116903,2,cell,O
116903,2,count,O
116903,2,of,O
116903,2,5.6,O
116903,2,",",O
116903,2,his,O
116903,2,hematocrit,O
116903,2,was,O
116903,2,28.4,O
116903,2,",",O
116903,2,and,O
116903,2,he,O
116903,2,had,O
116903,2,platelets,O
116903,2,of,O
116903,2,101,O
116903,2,.,O
116903,2,He,O
116903,2,had,O
116903,2,an,O
116903,2,INR,O
116903,2,of,O
116903,2,1.9,O
116903,2,.,O
116903,2,Chemistry-7,O
116903,2,showed,O
116903,2,an,O
116903,2,initial,O
116903,2,creatinine,O
116903,2,of,O
116903,2,4.2,O
116903,2,with,O
116903,2,a,O
116903,2,potassium,O
116903,2,of,O
116903,2,6.7,O
116903,2,.,O
116903,2,After,O
116903,2,gentle,O
116903,2,fluids,O
116903,2,and,O
116903,2,treatment,O
116903,2,for,O
116903,2,his,O
116903,2,potassium,O
116903,2,",",O
116903,2,he,O
116903,2,had,O
116903,2,a,O
116903,2,repeat,O
116903,2,potassium,O
116903,2,of,O
116903,2,5.7,O
116903,2,and,O
116903,2,a,O
116903,2,creatinine,O
116903,2,of,O
116903,2,3.9,O
116903,2,.,O
116903,2,He,O
116903,2,had,O
116903,2,an,O
116903,2,alanine-aminotransferase,O
116903,2,of,O
116903,2,57,O
116903,2,",",O
116903,2,his,O
116903,2,aspartate,O
116903,2,aminotransferase,O
116903,2,was,O
116903,2,166,O
116903,2,",",O
116903,2,his,O
116903,2,alkaline,O
116903,2,phosphatase,O
116903,2,was,O
116903,2,101,O
116903,2,",",O
116903,2,and,O
116903,2,his,O
116903,2,total,O
116903,2,bilirubin,O
116903,2,was,O
116903,2,3.7,O
116903,2,.,O
116903,2,PERTINENT,O
116903,2,RADIOLOGY/IMAGING,O
116903,2,:,O
116903,2,An,O
116903,2,electrocardiogram,O
116903,2,showed,O
116903,2,a,O
116903,2,normal,O
116903,2,sinus,O
116903,2,rhythm,O
116903,2,.,O
116903,2,There,O
116903,2,were,O
116903,2,no,O
116903,2,peaked,O
116903,2,T,O
116903,2,waves,O
116903,2,.,O
116903,2,Otherwise,O
116903,2,",",O
116903,2,his,O
116903,2,electrocardiogram,O
116903,2,was,O
116903,2,normal,O
116903,2,.,O
116903,2,BRIEF,O
116903,2,SUMMARY,O
116903,2,OF,O
116903,2,HOSPITAL,O
116903,2,COURSE,O
116903,2,:,O
116903,2,The,O
116903,2,patient,O
116903,2,was,O
116903,2,admitted,O
116903,2,for,O
116903,2,his,O
116903,2,acute,B-ADE
116903,2,renal,I-ADE
116903,2,insufficiency,I-ADE
116903,2,.,O
116903,2,His,O
116903,2,Lasix,B-Drug
116903,2,and,O
116903,2,his,O
116903,2,Aldactone,B-Drug
116903,2,were,O
116903,2,held,O
116903,2,.,O
116903,2,His,O
116903,2,hyperkalemia,B-Reason
116903,2,responded,O
116903,2,well,O
116903,2,to,O
116903,2,his,O
116903,2,Kayexalate,B-Drug
116903,2,therapy,O
116903,2,.,O
116903,2,The,O
116903,2,patient,O
116903,2,was,O
116903,2,noted,O
116903,2,to,O
116903,2,have,O
116903,2,some,O
116903,2,mild,O
116903,2,periorbital,O
116903,2,erythema,O
116903,2,and,O
116903,2,edema,O
116903,2,on,O
116903,2,the,O
116903,2,right,O
116903,2,side,O
116903,2,of,O
116903,2,his,O
116903,2,face,O
116903,2,.,O
116903,2,He,O
116903,2,was,O
116903,2,initially,O
116903,2,started,O
116903,2,on,O
116903,3,doxycycline,B-Drug
116903,3,for,O
116903,3,this,O
116903,3,presumed,B-Reason
116903,3,preseptal,I-Reason
116903,3,cellulitis,I-Reason
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,'s,O
116903,3,creatinine,O
116903,3,did,O
116903,3,initially,O
116903,3,improve,O
116903,3,;,O
116903,3,however,O
116903,3,",",O
116903,3,it,O
116903,3,started,O
116903,3,to,O
116903,3,increase,O
116903,3,again,O
116903,3,slowly,O
116903,3,during,O
116903,3,the,O
116903,3,course,O
116903,3,of,O
116903,3,his,O
116903,3,hospital,O
116903,3,stay,O
116903,3,.,O
116903,3,Initially,O
116903,3,",",O
116903,3,it,O
116903,3,was,O
116903,3,felt,O
116903,3,that,O
116903,3,the,O
116903,3,patient's,O
116903,3,initial,O
116903,3,presentation,O
116903,3,of,O
116903,3,acute,B-ADE
116903,3,renal,I-ADE
116903,3,insufficiency,I-ADE
116903,3,was,O
116903,3,secondary,O
116903,3,to,O
116903,3,aggressive,O
116903,3,diuresis,B-Drug
116903,3,;,O
116903,3,however,O
116903,3,",",O
116903,3,in,O
116903,3,the,O
116903,3,setting,O
116903,3,of,O
116903,3,his,O
116903,3,diuretics,O
116903,3,being,O
116903,3,held,O
116903,3,and,O
116903,3,his,O
116903,3,continued,O
116903,3,increase,O
116903,3,in,O
116903,3,his,O
116903,3,creatinine,O
116903,3,",",O
116903,3,it,O
116903,3,was,O
116903,3,possible,O
116903,3,that,O
116903,3,he,O
116903,3,could,O
116903,3,have,O
116903,3,the,O
116903,3,initial,O
116903,3,stages,O
116903,3,of,O
116903,3,hepatorenal,O
116903,3,syndrome,O
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,has,O
116903,3,had,O
116903,3,elevated,O
116903,3,creatinines,O
116903,3,on,O
116903,3,previous,O
116903,3,hospitalizations,O
116903,3,",",O
116903,3,presumed,O
116903,3,to,O
116903,3,be,O
116903,3,related,O
116903,3,to,O
116903,3,hepatorenal,B-Reason
116903,3,syndrome,I-Reason
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,was,O
116903,3,started,O
116903,3,on,O
116903,3,octreotide,B-Drug
116903,3,and,O
116903,3,midodrine,B-Drug
116903,3,.,O
116903,3,Also,O
116903,3,in,O
116903,3,the,O
116903,3,setting,O
116903,3,of,O
116903,3,his,O
116903,3,acute,B-ADE
116903,3,renal,I-ADE
116903,3,insufficiency,I-ADE
116903,3,",",O
116903,3,his,O
116903,3,tetracycline,B-Drug
116903,3,was,O
116903,3,held,O
116903,3,as,O
116903,3,it,O
116903,3,was,O
116903,3,possible,O
116903,3,that,O
116903,3,this,O
116903,3,could,O
116903,3,be,O
116903,3,a,O
116903,3,contributing,O
116903,3,factor,O
116903,3,.,O
116903,3,An,O
116903,3,Ophthalmology,O
116903,3,consultation,O
116903,3,was,O
116903,3,obtained,O
116903,3,which,O
116903,3,showed,O
116903,3,just,O
116903,3,some,O
116903,3,very,O
116903,3,mild,B-Reason
116903,3,preseptal,I-Reason
116903,3,cellulitis,I-Reason
116903,3,with,O
116903,3,no,O
116903,3,orbital,O
116903,3,signs,O
116903,3,or,O
116903,3,symptoms,O
116903,3,suggestive,O
116903,3,of,O
116903,3,an,O
116903,3,orbital,B-Reason
116903,3,cellulitis,I-Reason
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,'s,O
116903,3,doxycycline,B-Drug
116903,3,was,O
116903,3,discontinued,O
116903,3,in,O
116903,3,favor,O
116903,3,of,O
116903,3,Keflex,B-Drug
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,did,O
116903,3,have,O
116903,3,urine,O
116903,3,eosinophils,O
116903,3,and,O
116903,3,sediment,O
116903,3,checked,O
116903,3,.,O
116903,3,He,O
116903,3,had,O
116903,3,bland,O
116903,3,sediment,O
116903,3,which,O
116903,3,was,O
116903,3,not,O
116903,3,consistent,O
116903,3,with,O
116903,3,an,O
116903,3,acute,O
116903,3,tubular,O
116903,3,necrosis,O
116903,3,type,O
116903,3,picture,O
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,was,O
116903,3,also,O
116903,3,transfused,O
116903,3,with,O
116903,3,2,O
116903,3,units,O
116903,3,of,O
116903,3,packed,B-Drug
116903,3,red,I-Drug
116903,3,blood,I-Drug
116903,3,cells,I-Drug
116903,3,for,O
116903,3,a,O
116903,3,low,B-Reason
116903,3,hematocrit,I-Reason
116903,3,early,O
116903,3,on,O
116903,3,during,O
116903,3,the,O
116903,3,course,O
116903,3,of,O
116903,3,his,O
116903,3,hospital,O
116903,3,stay,O
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,did,O
116903,3,not,O
116903,3,have,O
116903,3,any,O
116903,3,upper,O
116903,3,endoscopy,O
116903,3,as,O
116903,3,his,O
116903,3,anemia,O
116903,3,was,O
116903,3,not,O
116903,3,suspected,O
116903,3,to,O
116903,3,be,O
116903,3,secondary,O
116903,3,to,O
116903,3,esophageal,O
116903,3,varices,O
116903,3,.,O
116903,3,The,O
116903,3,patient,O
116903,3,'s,O
116903,3,creatinine,B-ADE
116903,3,continued,I-ADE
116903,3,to,I-ADE
116903,3,rise,I-ADE
116903,3,in,O
116903,3,the,O
116903,3,setting,O
116903,3,of,O
116903,3,his,O
116903,3,octreotide,B-Drug
116903,3,and,O
116903,3,midodrine,B-Drug
116903,3,therapy,O
116903,3,.,O
116903,3,Because,O
116903,3,of,O
116903,3,this,O
116903,3,",",O
116903,3,albumin,B-Drug
116903,3,25,O
116903,3,grams,O
116903,3,intravenously,O
116903,3,once,O
116903,3,per,O
116903,3,day,O
116903,3,was,O
116903,3,also,O
116903,3,started,O
116903,3,.,O
116903,3,On,O
116903,3,[,O
116903,3,**2138-3-29**,O
116903,3,],O
116903,3,",",O
116903,3,the,O
116903,3,patient,O
116903,3,became,O
116903,3,encephalopathic,O
116903,3,.,O
116903,3,Blood,O
116903,3,cultures,O
116903,3,and,O
116903,3,urine,O
116903,3,cultures,O
116903,3,were,O
116903,3,sent,O
116903,3,",",O
116903,3,and,O
116903,3,he,O
116903,3,did,O
116903,3,have,O
116903,4,an,O
116903,4,episode,O
116903,4,of,O
116903,4,occult-blood,O
116903,4,positive,O
116903,4,stools,O
116903,4,.,O
116903,4,In,O
116903,4,the,O
116903,4,setting,O
116903,4,of,O
116903,4,his,O
116903,4,encephalopathy,B-Reason
116903,4,",",O
116903,4,his,O
116903,4,renal,O
116903,4,function,O
116903,4,did,O
116903,4,improve,O
116903,4,;,O
116903,4,however,O
116903,4,",",O
116903,4,he,O
116903,4,was,O
116903,4,transferred,O
116903,4,to,O
116903,4,the,O
116903,4,Unit,O
116903,4,for,O
116903,4,further,O
116903,4,observation,O
116903,4,.,O
116903,4,A,O
116903,4,nasogastric,O
116903,4,lavage,B-Drug
116903,4,was,O
116903,4,done,O
116903,4,in,O
116903,4,the,O
116903,4,setting,O
116903,4,of,O
116903,4,his,O
116903,4,occult-blood,B-Reason
116903,4,positive,I-Reason
116903,4,stool,I-Reason
116903,4,.,O
116903,4,The,O
116903,4,nasogastric,O
116903,4,lavage,B-Drug
116903,4,was,O
116903,4,negative,O
116903,4,for,O
116903,4,blood,O
116903,4,.,O
116903,4,He,O
116903,4,did,O
116903,4,have,O
116903,4,a,O
116903,4,STAT,O
116903,4,head,O
116903,4,computed,O
116903,4,tomography,O
116903,4,which,O
116903,4,was,O
116903,4,negative,O
116903,4,for,O
116903,4,bleed,O
116903,4,.,O
116903,4,All,O
116903,4,sedatives,B-Drug
116903,4,were,O
116903,4,discontinued,O
116903,4,",",O
116903,4,and,O
116903,4,he,O
116903,4,was,O
116903,4,started,O
116903,4,on,O
116903,4,lactulose,B-Drug
116903,4,therapy,O
116903,4,.,O
116903,4,A,O
116903,4,chest,O
116903,4,x-ray,O
116903,4,there,O
116903,4,was,O
116903,4,negative,O
116903,4,for,O
116903,4,a,O
116903,4,pneumonia,O
116903,4,.,O
116903,4,The,O
116903,4,patient,O
116903,4,did,O
116903,4,have,O
116903,4,serial,O
116903,4,blood,O
116903,4,cultures,O
116903,4,done,O
116903,4,.,O
116903,4,He,O
116903,4,did,O
116903,4,have,O
116903,4,a,O
116903,4,total,O
116903,4,of,O
116903,4,[,O
116903,4,**6-26**,O
116903,4,],O
116903,4,blood,O
116903,4,cultures,O
116903,4,positive,O
116903,4,for,O
116903,4,methicillin-resistant,O
116903,4,coagulase-negative,O
116903,4,Staphylococcus,O
116903,4,.,O
116903,4,His,O
116903,4,mental,B-Reason
116903,4,status,I-Reason
116903,4,did,O
116903,4,improve,O
116903,4,on,O
116903,4,lactulose,B-Drug
116903,4,therapy,O
116903,4,.,O
116903,4,The,O
116903,4,origin,O
116903,4,of,O
116903,4,his,O
116903,4,staphylococcal,B-Reason
116903,4,bacteremia,I-Reason
116903,4,was,O
116903,4,still,O
116903,4,uncertain,O
116903,4,.,O
116903,4,In,O
116903,4,this,O
116903,4,setting,O
116903,4,",",O
116903,4,he,O
116903,4,did,O
116903,4,have,O
116903,4,a,O
116903,4,diagnostic,O
116903,4,paracentesis,O
116903,4,done,O
116903,4,which,O
116903,4,was,O
116903,4,negative,O
116903,4,for,O
116903,4,spontaneous,O
116903,4,bacterial,O
116903,4,peritonitis,O
116903,4,.,O
116903,4,The,O
116903,4,patient,O
116903,4,was,O
116903,4,started,O
116903,4,on,O
116903,4,vancomycin,B-Drug
116903,4,for,O
116903,4,his,O
116903,4,high-grade,B-Reason
116903,4,bacteremia,I-Reason
116903,4,.,O
116903,4,He,O
116903,4,did,O
116903,4,have,O
116903,4,a,O
116903,4,transesophageal,O
116903,4,echocardiogram,O
116903,4,done,O
116903,4,which,O
116903,4,was,O
116903,4,negative,O
116903,4,for,O
116903,4,endocarditis,O
116903,4,.,O
116903,4,Per,O
116903,4,the,O
116903,4,Infectious,O
116903,4,Disease,O
116903,4,staff,O
116903,4,",",O
116903,4,it,O
116903,4,was,O
116903,4,recommended,O
116903,4,that,O
116903,4,he,O
116903,4,be,O
116903,4,treated,O
116903,4,with,O
116903,4,four,O
116903,4,to,O
116903,4,six,O
116903,4,weeks,O
116903,4,of,O
116903,4,vancomycin,B-Drug
116903,4,from,O
116903,4,the,O
116903,4,date,O
116903,4,of,O
116903,4,his,O
116903,4,last,O
116903,4,positive,O
116903,4,blood,O
116903,4,cultures,O
116903,4,which,O
116903,4,were,O
116903,4,[,O
116903,4,**2138-3-30**,O
116903,4,],O
116903,4,.,O
116903,4,The,O
116903,4,patient,O
116903,4,was,O
116903,4,transferred,O
116903,4,back,O
116903,4,to,O
116903,4,the,O
116903,4,floor,O
116903,4,with,O
116903,4,an,O
116903,4,improved,O
116903,4,mental,O
116903,4,status,O
116903,4,and,O
116903,4,improved,O
116903,4,renal,O
116903,4,function,O
116903,4,.,O
116903,4,He,O
116903,4,did,O
116903,4,well,O
116903,4,on,O
116903,4,the,O
116903,4,floor,O
116903,4,.,O
116903,4,His,O
116903,4,hematocrit,O
116903,4,remained,O
116903,4,stable,O
116903,4,.,O
116903,4,He,O
116903,4,remained,O
116903,4,afebrile,O
116903,4,on,O
116903,4,vancomycin,B-Drug
116903,4,.,O
116903,4,The,O
116903,4,patient,O
116903,4,also,O
116903,4,completed,O
116903,4,a,O
116903,4,course,O
116903,4,of,O
116903,4,levofloxacin,B-Drug
116903,4,for,O
116903,4,his,O
116903,4,preseptal,B-Reason
116903,4,cellulitis,I-Reason
116903,4,.,O
116903,4,For,O
116903,4,his,O
116903,4,preseptal,B-Reason
116903,4,cellulitis,I-Reason
116903,4,",",O
116903,4,he,O
116903,4,received,O
116903,4,a,O
116903,4,total,O
116903,4,of,O
116903,4,10,O
116903,4,days,O
116903,4,of,O
116903,4,antibiotics,B-Drug
116903,4,which,O
116903,4,included,O
116903,4,doxycycline,B-Drug
116903,4,",",O
116903,4,Keflex,B-Drug
116903,4,",",O
116903,4,and,O
116903,4,levofloxacin,B-Drug
116903,4,.,O
116903,4,The,O
116903,4,patient,O
116903,4,did,O
116903,4,have,O
116903,4,good,O
116903,4,nutritional,O
116903,4,intake,O
116903,4,while,O
116903,4,on,O
116903,4,the,O
116903,4,floor,O
116903,4,.,O
116903,4,His,O
116903,4,creatinine,O
116903,5,remained,O
116903,5,in,O
116903,5,the,O
116903,5,1.6,O
116903,5,to,O
116903,5,1.9,O
116903,5,range,O
116903,5,on,O
116903,5,the,O
116903,5,floor,O
116903,5,and,O
116903,5,stable,O
116903,5,.,O
116903,5,His,O
116903,5,baseline,O
116903,5,creatinine,O
116903,5,is,O
116903,5,around,O
116903,5,1,O
116903,5,.,O
116903,5,He,O
116903,5,was,O
116903,5,not,O
116903,5,started,O
116903,5,on,O
116903,5,diuretics,B-Drug
116903,5,at,O
116903,5,discharge,O
116903,5,.,O
116903,5,A,O
116903,5,peripherally,O
116903,5,inserted,O
116903,5,central,O
116903,5,catheter,O
116903,5,line,O
116903,5,was,O
116903,5,placed,O
116903,5,for,O
116903,5,administration,O
116903,5,of,O
116903,5,intravenous,O
116903,5,vancomycin,B-Drug
116903,5,for,O
116903,5,his,O
116903,5,high-grade,O
116903,5,methicillin-resistant,O
116903,5,Staphylococcus,O
116903,5,epidermitis,O
116903,5,bacteremia,O
116903,5,.,O
116903,5,The,O
116903,5,patient,O
116903,5,was,O
116903,5,seen,O
116903,5,by,O
116903,5,Physical,O
116903,5,Therapy,O
116903,5,and,O
116903,5,was,O
116903,5,discharged,O
116903,5,from,O
116903,5,their,O
116903,5,service,O
116903,5,as,O
116903,5,he,O
116903,5,had,O
116903,5,no,O
116903,5,acute,O
116903,5,physical,O
116903,5,therapy,O
116903,5,needs,O
116903,5,.,O
116903,5,The,O
116903,5,patient,O
116903,5,did,O
116903,5,have,O
116903,5,a,O
116903,5,candidal,B-Reason
116903,5,infection,I-Reason
116903,5,of,I-Reason
116903,5,his,I-Reason
116903,5,groin,I-Reason
116903,5,area,I-Reason
116903,5,which,O
116903,5,was,O
116903,5,treated,O
116903,5,with,O
116903,5,topical,O
116903,5,anti-fungal,B-Drug
116903,5,medications,I-Drug
116903,5,",",O
116903,5,to,O
116903,5,which,O
116903,5,he,O
116903,5,responded,O
116903,5,well,O
116903,5,to,O
116903,5,.,O
116903,5,Toward,O
116903,5,the,O
116903,5,end,O
116903,5,of,O
116903,5,his,O
116903,5,hospital,O
116903,5,stay,O
116903,5,",",O
116903,5,the,O
116903,5,patient,O
116903,5,did,O
116903,5,have,O
116903,5,increased,O
116903,5,diarrhea,O
116903,5,.,O
116903,5,His,O
116903,5,lactulose,B-Drug
116903,5,was,O
116903,5,held,O
116903,5,which,O
116903,5,improved,O
116903,5,his,O
116903,5,diarrhea,B-ADE
116903,5,somewhat,O
116903,5,;,O
116903,5,however,O
116903,5,",",O
116903,5,he,O
116903,5,did,O
116903,5,complain,O
116903,5,of,O
116903,5,increased,O
116903,5,diarrhea,O
116903,5,.,O
116903,5,He,O
116903,5,did,O
116903,5,have,O
116903,5,Clostridium,O
116903,5,difficile,O
116903,5,toxins,O
116903,5,times,O
116903,5,three,O
116903,5,days,O
116903,5,which,O
116903,5,were,O
116903,5,sent,O
116903,5,.,O
116903,5,These,O
116903,5,were,O
116903,5,negative,O
116903,5,for,O
116903,5,Clostridium,O
116903,5,difficile,O
116903,5,.,O
116903,5,The,O
116903,5,patient,O
116903,5,was,O
116903,5,discharged,O
116903,5,on,O
116903,5,no,O
116903,5,diuretics,B-Drug
116903,5,;,O
116903,5,however,O
116903,5,",",O
116903,5,the,O
116903,5,possibility,O
116903,5,of,O
116903,5,restarting,O
116903,5,Aldactone,B-Drug
116903,5,50,O
116903,5,mg,O
116903,5,will,O
116903,5,be,O
116903,5,considered,O
116903,5,as,O
116903,5,an,O
116903,5,outpatient,O
116903,5,.,O
116903,5,He,O
116903,5,will,O
116903,5,be,O
116903,5,discharged,O
116903,5,with,O
116903,5,a,O
116903,5,total,O
116903,5,course,O
116903,5,of,O
116903,5,four,O
116903,5,to,O
116903,5,six,O
116903,5,weeks,O
116903,5,of,O
116903,5,vancomycin,B-Drug
116903,5,.,O
116903,5,The,O
116903,5,start,O
116903,5,date,O
116903,5,on,O
116903,5,his,O
116903,5,vancomycin,B-Drug
116903,5,was,O
116903,5,[,O
116903,5,**2138-3-30**,O
116903,5,],O
116903,5,.,O
116903,5,CONDITION,O
116903,5,AT,O
116903,5,DISCHARGE,O
116903,5,:,O
116903,5,Fair,O
116903,5,.,O
116903,5,DISCHARGE,O
116903,5,STATUS,O
116903,5,:,O
116903,5,To,O
116903,5,home,O
116903,5,.,O
116903,5,DISCHARGE,O
116903,5,DIAGNOSES,O
116903,5,:,O
116903,5,1,O
116903,5,.,O
116903,5,Hepatitis,O
116903,5,C,O
116903,5,cirrhosis,O
116903,5,;,O
116903,5,awaiting,O
116903,5,liver,O
116903,5,transplantation,O
116903,5,.,O
116903,5,2,O
116903,5,.,O
116903,5,Acute,O
116903,5,renal,O
116903,5,failure,O
116903,5,.,O
116903,5,3,O
116903,5,.,O
116903,5,Methicillin-resistant,B-Reason
116903,5,coagulase-negative,I-Reason
116903,5,staphylococcal,I-Reason
116903,5,bacteremia,I-Reason
116903,5,;,O
116903,5,on,O
116903,5,vancomycin,B-Drug
116903,5,.,O
116903,5,MEDICATIONS,O
116903,5,ON,O
116903,5,DISCHARGE,O
116903,5,:,O
116903,5,1,O
116903,5,.,O
116903,5,Miconazole,B-Drug
116903,5,nitrate,I-Drug
116903,5,powder,O
116903,5,applied,O
116903,5,three,O
116903,5,times,O
116903,5,per,O
116903,5,day,O
116903,5,as,O
116903,5,needed,O
116903,5,to,O
116903,5,groin,B-Reason
116903,5,rash,I-Reason
116903,5,.,O
116903,5,2,O
116903,5,.,O
116903,5,Protonix,B-Drug
116903,5,40,O
116903,5,mg,O
116903,5,q.12h,O
116903,5,.,O
116903,5,3,O
116903,5,.,O
116903,5,Lactulose,B-Drug
116903,5,30,O
116903,5,mL,O
116903,5,by,O
116903,5,mouth,O
116903,5,three,O
116903,5,times,O
116903,5,per,O
116903,5,day,O
116903,5,(,O
116903,5,titrated,O
116903,5,to,O
116903,5,four,O
116903,5,to,O
116903,5,five,O
116903,5,bowel,O
116903,5,movements,O
116903,5,per,O
116903,5,day,O
116903,5,),O
116903,5,.,O
116903,5,4,O
116903,5,.,O
116903,5,Vancomycin,B-Drug
116903,5,1,O
116903,5,gram,O
116903,5,intravenously,O
116903,6,q.12h,O
116903,6,.,O
116903,6,(,O
116903,6,for,O
116903,6,a,O
116903,6,total,O
116903,6,of,O
116903,6,six,O
116903,6,weeks,O
116903,6,),O
116903,6,;,O
116903,6,his,O
116903,6,vancomycin,B-Drug
116903,6,dose,O
116903,6,will,O
116903,6,be,O
116903,6,changed,O
116903,6,per,O
116903,6,trough,O
116903,6,levels,O
116903,6,and,O
116903,6,his,O
116903,6,renal,O
116903,6,function,O
116903,6,.,O
116903,6,DISCHARGE,O
116903,6,INSTRUCTIONS/FOLLOWUP,O
116903,6,:,O
116903,6,The,O
116903,6,patient,O
116903,6,was,O
116903,6,to,O
116903,6,follow,O
116903,6,up,O
116903,6,in,O
116903,6,the,O
116903,6,Liver,O
116903,6,Clinic,O
116903,6,in,O
116903,6,two,O
116903,6,days,O
116903,6,from,O
116903,6,discharge,O
116903,6,.,O
116903,6,[,O
116903,6,**First,O
116903,6,Name11,O
116903,6,(,O
116903,6,Name,O
116903,6,Pattern1,O
116903,6,),O
116903,6,**,O
116903,6,],O
116903,6,[,O
116903,6,**Last,O
116903,6,Name,O
116903,6,(,O
116903,6,NamePattern1,O
116903,6,),O
116903,6,8507**,O
116903,6,],O
116903,6,",",O
116903,6,M.D,O
116903,6,.,O
116903,6,[,O
116903,6,**MD,O
116903,6,Number,O
116903,6,(,O
116903,6,2,O
116903,6,),O
116903,6,22654**,O
116903,6,],O
116903,6,Dictated,O
116903,6,By,O
116903,6,:,O
116903,6,[,O
116903,6,**Last,O
116903,6,Name,O
116903,6,(,O
116903,6,NamePattern1,O
116903,6,),O
116903,6,11207**,O
116903,6,],O
116903,6,MEDQUIST36,O
116903,6,D,O
116903,6,:,O
116903,6,[,O
116903,6,**2138-4-7**,O
116903,6,],O
116903,6,15:21,O
116903,6,T,O
116903,6,:,O
116903,6,[,O
116903,6,**2138-4-9**,O
116903,6,],O
116903,6,07:33,O
116903,6,JOB,O
116903,6,#,O
116903,6,:,O
116903,6,[,O
116903,6,**Job,O
116903,6,Number,O
116903,6,25451**,O
116903,6,],O
